319 related articles for article (PubMed ID: 22489665)
1. MMP-Cliffs: systematic identification of activity cliffs on the basis of matched molecular pairs.
Hu X; Hu Y; Vogt M; Stumpfe D; Bajorath J
J Chem Inf Model; 2012 May; 52(5):1138-45. PubMed ID: 22489665
[TBL] [Abstract][Full Text] [Related]
2. From activity cliffs to activity ridges: informative data structures for SAR analysis.
Vogt M; Huang Y; Bajorath J
J Chem Inf Model; 2011 Aug; 51(8):1848-56. PubMed ID: 21761918
[TBL] [Abstract][Full Text] [Related]
3. Extending the activity cliff concept: structural categorization of activity cliffs and systematic identification of different types of cliffs in the ChEMBL database.
Hu Y; Bajorath J
J Chem Inf Model; 2012 Jul; 52(7):1806-11. PubMed ID: 22758389
[TBL] [Abstract][Full Text] [Related]
4. Exploration of 3D activity cliffs on the basis of compound binding modes and comparison of 2D and 3D cliffs.
Hu Y; Bajorath J
J Chem Inf Model; 2012 Mar; 52(3):670-7. PubMed ID: 22394306
[TBL] [Abstract][Full Text] [Related]
5. Do medicinal chemists learn from activity cliffs? A systematic evaluation of cliff progression in evolving compound data sets.
Dimova D; Heikamp K; Stumpfe D; Bajorath J
J Med Chem; 2013 Apr; 56(8):3339-45. PubMed ID: 23527828
[TBL] [Abstract][Full Text] [Related]
6. Chemical substitutions that introduce activity cliffs across different compound classes and biological targets.
Wassermann AM; Bajorath J
J Chem Inf Model; 2010 Jul; 50(7):1248-56. PubMed ID: 20608746
[TBL] [Abstract][Full Text] [Related]
7. Systematic identification and classification of three-dimensional activity cliffs.
Hu Y; Furtmann N; Gütschow M; Bajorath J
J Chem Inf Model; 2012 Jun; 52(6):1490-8. PubMed ID: 22612566
[TBL] [Abstract][Full Text] [Related]
8. Molecular scaffolds with high propensity to form multi-target activity cliffs.
Hu Y; Bajorath J
J Chem Inf Model; 2010 Apr; 50(4):500-10. PubMed ID: 20361784
[TBL] [Abstract][Full Text] [Related]
9. Prediction of individual compounds forming activity cliffs using emerging chemical patterns.
Namasivayam V; Iyer P; Bajorath J
J Chem Inf Model; 2013 Dec; 53(12):3131-9. PubMed ID: 24304008
[TBL] [Abstract][Full Text] [Related]
10. Method for the evaluation of structure-activity relationship information associated with coordinated activity cliffs.
Dimova D; Stumpfe D; Bajorath J
J Med Chem; 2014 Aug; 57(15):6553-63. PubMed ID: 25014781
[TBL] [Abstract][Full Text] [Related]
11. Comprehensive analysis of single- and multi-target activity cliffs formed by currently available bioactive compounds.
Wassermann AM; Dimova D; Bajorath J
Chem Biol Drug Des; 2011 Aug; 78(2):224-8. PubMed ID: 21624090
[TBL] [Abstract][Full Text] [Related]
12. Frequency of occurrence and potency range distribution of activity cliffs in bioactive compounds.
Stumpfe D; Bajorath J
J Chem Inf Model; 2012 Sep; 52(9):2348-53. PubMed ID: 22866827
[TBL] [Abstract][Full Text] [Related]
13. From structure-activity to structure-selectivity relationships: quantitative assessment, selectivity cliffs, and key compounds.
Peltason L; Hu Y; Bajorath J
ChemMedChem; 2009 Nov; 4(11):1864-73. PubMed ID: 19750525
[TBL] [Abstract][Full Text] [Related]
14. Activity cliff networks for medicinal chemistry.
Stumpfe D; Bajorath J
Drug Dev Res; 2014 Aug; 75(5):291-8. PubMed ID: 25160069
[TBL] [Abstract][Full Text] [Related]
15. Prediction of activity cliffs using support vector machines.
Heikamp K; Hu X; Yan A; Bajorath J
J Chem Inf Model; 2012 Sep; 52(9):2354-65. PubMed ID: 22894655
[TBL] [Abstract][Full Text] [Related]
16. Matched molecular pair analysis of small molecule microarray data identifies promiscuity cliffs and reveals molecular origins of extreme compound promiscuity.
Dimova D; Hu Y; Bajorath J
J Med Chem; 2012 Nov; 55(22):10220-8. PubMed ID: 23050678
[TBL] [Abstract][Full Text] [Related]
17. Structural interpretation of activity cliffs revealed by systematic analysis of structure-activity relationships in analog series.
Sisay MT; Peltason L; Bajorath J
J Chem Inf Model; 2009 Oct; 49(10):2179-89. PubMed ID: 19761254
[TBL] [Abstract][Full Text] [Related]
18. Exploring SAR continuity in the vicinity of activity cliffs.
Namasivayam V; Iyer P; Bajorath J
Chem Biol Drug Des; 2012 Jan; 79(1):22-9. PubMed ID: 21985661
[TBL] [Abstract][Full Text] [Related]
19. Recent progress in understanding activity cliffs and their utility in medicinal chemistry.
Stumpfe D; Hu Y; Dimova D; Bajorath J
J Med Chem; 2014 Jan; 57(1):18-28. PubMed ID: 23981118
[TBL] [Abstract][Full Text] [Related]
20. Chemical landscape analysis with the OpenTox framework.
Jeliazkova N; Jeliazkov V
Curr Top Med Chem; 2012; 12(18):1987-2001. PubMed ID: 23110534
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
